Early costs and complications of first-line low-grade glioma treatment using a large national database: Limitations and future perspectives

IntroductionDiffuse Low-grade gliomas (DLGG, WHO Grade II) are a heterogenous group of tumors comprising 13–16% of glial tumors. While maximal safe resection is endorsed as the best approach to DLGG, compared to more conservative interventions like stereotactic biopsy, the added costs and risks have...

Descrición completa

Detalles Bibliográficos

Principais autores:	Kyle Tuohy, Djibril M. Ba, Debarati Bhanja, Douglas Leslie, Guodong Liu, Alireza Mansouri
Formato:	Artigo
Idioma:	Inglês
Publicado:	Frontiers Media S.A. 2023-02-01
Series:	Frontiers in Surgery
Assuntos:	low-grade glioma (WHO grade II) cost resection stereotactic biopsy adverse events—complications MarketScan database
Acceso en liña:	https://www.frontiersin.org/articles/10.3389/fsurg.2023.1001741/full
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!